Publication 7/01/2001

Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.

Tada H, Maron DJ, Choi EA, Barsoum J, Lei H, Xie Q, Liu W, Ellis L, Moscioni AD, Tazelaar J, Fawell S, Qin X, Propert KJ, Davis A, Fraker DL, Wilson JM, Spitz FR

The Journal Of Clinical Investigation

Publication 11/26/1999

Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty.

Claudio PP, Fratta L, Farina F, Howard CM, Stassi G, Numata S, Pacilio C, Davis A, Lavitrano M, Volpe M, Wilson JM, Trimarco B, Giordano A, Condorelli G

Circulation Research

Publication 11/24/1998

Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice.

Qin XQ, Tao N, Dergay A, Moy P, Fawell S, Davis A, Wilson JM, Barsoum J

Proceedings Of The National Academy Of Sciences Of The United States Of America

Publication 10/20/1996

Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274).

Treat J, Kaiser LR, Sterman DH, Litzky L, Davis A, Wilson JM, Albelda SM

Human Gene Therapy

Publication 8/01/1996

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM

Human Gene Therapy